A detailed history of Maven Securities LTD transactions in Axonics, Inc. stock. As of the latest transaction made, Maven Securities LTD holds 15,000 shares of AXNX stock, worth $1.04 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
15,000
Previous 15,000 -0.0%
Holding current value
$1.04 Million
Previous $1.01 Million -0.0%
% of portfolio
0.17%
Previous 0.14%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$66.47 - $69.65 $997,050 - $1.04 Million
15,000 New
15,000 $1.01 Million
Q3 2021

Nov 15, 2021

SELL
$59.21 - $78.66 $1.93 Million - $2.57 Million
-32,657 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$51.39 - $66.9 $376,328 - $489,908
7,323 Added 28.91%
32,657 $2.08 Million
Q1 2021

May 17, 2021

BUY
$49.14 - $59.89 $1.24 Million - $1.52 Million
25,334 New
25,334 $1.5 Million
Q1 2020

May 15, 2020

SELL
$16.44 - $37.73 $2.65 Million - $6.07 Million
-161,000 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$19.57 - $28.96 $3.15 Million - $4.66 Million
161,000 New
161,000 $4.34 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.41B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.